{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:50:48Z","timestamp":1790801448037,"version":"4.1.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Zepto Life Technology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Despite advances in clinical microbiology, the diagnosis of invasive fungal infections remains challenging. Giant magnetoresistance (GMR) is a novel technology that enables the detection of trace amounts of cell-free DNA (cfDNA). We evaluated a high-multiplex molecular diagnostic assay coupled with GMR-enabled lab-on-a-chip technology that can detect 18 different fungal species.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Analytical performance was evaluated in spiked plasma samples. After amplification, cfDNA was digested. Residual single-stranded DNA was flowed over a GMR sensor that was surface-coated with probes specific to different fungal species. After hybridization, magnetic beads bound to the probe complexes produced a GMR signal that was detected by the sensors. Clinical performance was determined using residual serum samples collected before the initiation of antifungal treatment from 20 patients with infection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The limit of detection of the assay ranged from 5 to 50 copies per polymerase chain reaction (PCR) reaction. Nonspecific signals were not observed in the spiked samples. Fungal cfDNA was detected in 80% of patients with invasive candidiasis (3\/4 with candidemia, 5\/6 with invasive candidiasis without candidemia), all 3 cases of invasive pulmonary aspergillosis, and all 3 cases of disseminated histoplasmosis. cfDNA was not detected in 2 patients with cryptococcosis (both had negative blood cultures) and 2 patients with Pneumocystis pneumonia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We developed a novel GMR-enabled multiplex PCR assay detecting fungal pathogens that have been prioritized for public health action. Clinical sensitivity was highest in cases of presumed angioinvasion and dissemination. This technology has the potential for use in the clinical microbiology laboratory setting.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf068","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T10:01:37Z","timestamp":1740477697000},"source":"Crossref","is-referenced-by-count":5,"title":["A Novel Giant Magnetoresistance\u2013Enabled Multiplex Polymerase Chain Reaction Assay for the Diagnosis of Invasive Fungal Infection"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6581-3956","authenticated-orcid":false,"given":"Paschalis","family":"Vergidis","sequence":"first","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3090-9261","authenticated-orcid":false,"given":"Eloy E","family":"Ordaya","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]},{"name":"Division of Infectious Diseases, Department of Medicine, Henry Ford Health , Detroit, Michigan ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Porter","sequence":"additional","affiliation":[{"name":"Zepto Life Technology, Inc , Saint Paul, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Sweet","sequence":"additional","affiliation":[{"name":"Zepto Life Technology, Inc , Saint Paul, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Zepto Life Technology, Inc , Saint Paul, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0702-3022","authenticated-orcid":false,"given":"Anton F","family":"Evans","sequence":"additional","affiliation":[{"name":"Zepto Life Technology, Inc , Saint Paul, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zepto Life Technology, Inc , Saint Paul, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4182-341X","authenticated-orcid":false,"given":"Jo-Anne H","family":"Young","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease and International Medicine, Department of Medicine, University of Minnesota , Minneapolis, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Liu","sequence":"additional","affiliation":[{"name":"Zepto Life Technology, Inc , Saint Paul, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"2025022510084074800_ofaf068-B1","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025022510084074800_ofaf068-B2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/cid\/ciac004","article-title":"Attributable mortality of Candida bloodstream infections in the modern era: a propensity score analysis","volume":"75","author":"Mazi","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025022510084074800_ofaf068-B3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(22)00872-6","article-title":"Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study","volume":"23","author":"Hoenigl","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2025022510084074800_ofaf068-B4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"2025022510084074800_ofaf068-B5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(21)00219-1","article-title":"Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial","volume":"397","author":"Maertens","year":"2021","journal-title":"Lancet"},{"key":"2025022510084074800_ofaf068-B6","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/cid\/ciac829","article-title":"Clinically adjudicated reference standards for evaluation of infectious diseases diagnostics","volume":"76","author":"Patel","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025022510084074800_ofaf068-B7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12929-023-00926-2","article-title":"Diagnosis of invasive fungal infections: challenges and recent developments","volume":"30","author":"Fang","year":"2023","journal-title":"J Biomed Sci"},{"key":"2025022510084074800_ofaf068-B8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/14737159.2022.2037423","article-title":"An overview of using fungal DNA for the diagnosis of invasive mycoses","volume":"22","author":"White","year":"2022","journal-title":"Expert Rev Mol Diagn"},{"key":"2025022510084074800_ofaf068-B9","doi-asserted-by":"crossref","DOI":"10.1016\/j.tim.2024.06.005","article-title":"Cell-free DNA: a promising biomarker in infectious diseases [manuscript published online ahead of print 11 July 2024]","author":"Hu","year":"2024","journal-title":"Trends Microbiol"},{"key":"2025022510084074800_ofaf068-B10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamaoncol.2019.4120","article-title":"Evaluation of plasma microbial cell-free DNA sequencing to predict bloodstream infection in pediatric patients with relapsed or refractory cancer","volume":"6","author":"Goggin","year":"2020","journal-title":"JAMA Oncol"},{"key":"2025022510084074800_ofaf068-B11","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.cmi.2024.03.003","article-title":"Diagnostic limitations and challenges in current clinical guidelines and potential application of metagenomic sequencing to manage pulmonary invasive fungal infections in patients with haematological malignancies","volume":"30","author":"Park","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"2025022510084074800_ofaf068-B12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.tibtech.2004.06.006","article-title":"Magnetoresistive-based biosensors and biochips","volume":"22","author":"Graham","year":"2004","journal-title":"Trends Biotechnol"},{"key":"2025022510084074800_ofaf068-B13","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.bios.2010.01.038","article-title":"GMR biosensor arrays: a system perspective","volume":"25","author":"Hall","year":"2010","journal-title":"Biosens Bioelectron"},{"key":"2025022510084074800_ofaf068-B14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bios.2018.10.046","article-title":"Development of a multiplexed giant magnetoresistive biosensor array prototype to quantify ovarian cancer biomarkers","volume":"126","author":"Klein","year":"2019","journal-title":"Biosens Bioelectron"},{"key":"2025022510084074800_ofaf068-B15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/jof10070449","article-title":"Daily fungal cell-free DNA testing to assess clinical status during Candida krusei fungemia","volume":"10","author":"Young","year":"2024","journal-title":"J Fungi (Basel)"},{"key":"2025022510084074800_ofaf068-B16","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025022510084074800_ofaf068-B17","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1021\/acsami.1c20141","article-title":"Giant magnetoresistance biosensors in biomedical applications","volume":"14","author":"Wu","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"2025022510084074800_ofaf068-B18","doi-asserted-by":"crossref","first-page":"102055","DOI":"10.1016\/j.tube.2021.102055","article-title":"Point-of-care detection of tuberculosis using magnetoresistive biosensing chip","volume":"127","author":"Gupta","year":"2021","journal-title":"Tuberculosis (Edinb)"},{"key":"2025022510084074800_ofaf068-B19","doi-asserted-by":"crossref","first-page":"122207","DOI":"10.1016\/j.talanta.2021.122207","article-title":"Anti-SARS-CoV-2 IgG and IgM detection with a GMR based LFIA system","volume":"227","author":"Bayin","year":"2021","journal-title":"Talanta"},{"key":"2025022510084074800_ofaf068-B20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fmicb.2016.00400","article-title":"Giant magnetoresistance-based biosensor for detection of influenza A virus","volume":"7","author":"Krishna","year":"2016","journal-title":"Front Microbiol"},{"key":"2025022510084074800_ofaf068-B21","doi-asserted-by":"crossref","first-page":"15615","DOI":"10.1038\/s41598-019-52147-z","article-title":"An automated, quantitative, and multiplexed assay suitable for point-of-care hepatitis B virus diagnostics","volume":"9","author":"Gani","year":"2019","journal-title":"Sci Rep"},{"key":"2025022510084074800_ofaf068-B22","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2025022510084074800_ofaf068-B23","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/cid\/ciad420","article-title":"Superior accuracy of Aspergillus plasma cell-free DNA polymerase chain reaction over serum galactomannan for the diagnosis of invasive aspergillosis","volume":"77","author":"Mah","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025022510084074800_ofaf068-B24","volume-title":"WHO fungal priority pathogens list to guide research, development and public health action","year":"2022"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/2\/ofaf068\/62164490\/ofaf068.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/2\/ofaf068\/62164490\/ofaf068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T10:08:57Z","timestamp":1740478137000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf068\/8041899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf068","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,1,31]]},"article-number":"ofaf068"}}